The following are some of the stocks that are trading below the Peter Lynch earnings line, according to GuruFocus' All-in-One Screener.
Citigroup Inc. (C) is trading at about $42, but the Peter Lynch earnings line gives the company a fair price of $57.62, giving the stock a margin of safety of 27%. It is trading with a PE ratio of 7.78 that is ranked higher than 78% of its competitors in the Global Banks - Global industry, and is currently 31.22% below its 52-week high and 21.44% above its 52-week low.
The company reports a cash to debt of 0.60 that is far below the industry median of 2.60, with ROE of 7.62% and ROA of 0.95% that are outperforming 58% of its competitors. It is a financial services holding company, whose businesses provide a range of financial products and services, including consumer banking, credit cards, corporate and investment banking, securities brokerage and wealth management.
The stock is part of 11 gurus portfolios: Barrow, Hanley, Mewhinney & Strauss is the main shareholder among the gurus with a stake of 0.73% of outstanding shares, followed by HOTCHKIS & WILEY with 0.53%, Ken Fisher (Trades, Portfolio) with 0.41%, First Pacific Advisors (Trades, Portfolio) with 0.38%, Steven Romick (Trades, Portfolio) with 0.33% and Bill Nygren (Trades, Portfolio) with 0.31%.
Jazz Pharmaceuticals PLCÂ (JAZZ) is trading at the price of $118.13, but the Peter Lynch earnings line gives the company a fair price of $130.75, giving the stock a margin of safety of 10%. It is trading with a PE ratio of 22.59 that is ranked higher than 66% of its competitors in the Global Biotechnology industry, and is currently 39.34% below its 52-week high and 8.88% above its 52-week low.
The company reports a cash to debt of 0.82 that is far below the industry median of 65.79, with ROE of 22.62% and ROA of 9.81% that are outperforming the 89% of its competitors. It is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.
The company is held by five gurus:Â RS Investment Management (Trades, Portfolio) is the largest shareholder among the gurus with a stake of 0.59% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.59%, Joel Greenblatt (Trades, Portfolio) with 0.3%, Louis Moore Bacon (Trades, Portfolio) with 0.06% and Jim Simons (Trades, Portfolio) with 0.03%.
Eastman Chemical Co. (EMN) is trading at the price of $72.78, but the Peter Lynch earnings line gives the company a fair price of $74.88, giving the stock a margin of safety of 3%. It is trading with a PE ratio of 12.87 that is ranked higher than 65% of its competitors in the Global Chemicals industry and is currently 13.15% below its 52-week high and 30.06% above its 52-week low.
The company reports a cash to debt of 0.04 that is below the industry median of 0.71, with ROE of 22.88% and ROA of 5.35% that are outperforming the 61% of its competitors. It is a specialty chemical company that produces a broad range of advanced materials, chemicals, and fibers that are found in products people use every day.
The stock is part of six gurus portfolios: First Eagle Investment (Trades, Portfolio) is the main shareholder among the gurus with a stake of 1.57% of outstanding shares, followed by Leon Cooperman (Trades, Portfolio) with 0.74%, Diamond Hill Capital (Trades, Portfolio) with 0.63%, David Tepper (Trades, Portfolio) with 0.47%, RS Investment Management (Trades, Portfolio) with 0.18% and Joel Greenblatt (Trades, Portfolio) with 0.1%.
Amgen Inc. (AMGN) is trading at the price of $148.37, but the Peter Lynch earnings line gives the company a fair price of $151.2, giving the stock a margin of safety of 2%. It is trading with a PE ratio of 16.36 that is ranked higher than 68% of its competitors in the Global Biotechnology industry and is currently 18.39% below its 52-week high and 14.05% above its 52-week low.
The company reports a cash to debt of 0.99 that is below the industry median of 65.79, with ROE of 25.55% and ROA of 9.84% that are outperforming 89% of its competitors. It is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics.
The stock is held by seven gurus:Â PRIMECAP Management (Trades, Portfolio) is the largest shareholder among the gurus with a stake of 3.88% of outstanding shares, followed by Daniel Loeb (Trades, Portfolio) with 1.2%, Vanguard Health Care Fund (Trades, Portfolio) with 0.72%, First Eagle Investment (Trades, Portfolio) with 0.13%, Jeremy Grantham (Trades, Portfolio) with 0.05% and Joel Greenblatt (Trades, Portfolio) with 0.04%.
Packaging Corp of America (PKG) is trading at the price of $58.94, but the Peter Lynch earnings line gives the company a fair price of $111.5, giving the stock a margin of safety of 47%. It is trading with a PE ratio of 13.22 that is ranked higher than 67% of its competitors in the Global Packaging & Containers industry, and is currently 25.50% below its 52-week high and 32.99% above its 52-week low.
The company reports a cash to debt of 0.08 that is above the industry median of 0.62, with ROE of 27.25% that is outperforming 8.16% of its competitors. It is engaged in manufacturing of containerboard and corrugated packaging products.Â
The stock is part of five guru portfolios: HOTCHKIS & WILEY is the main shareholder among the gurus with a stake of 1.03% of outstanding shares, followed by First Eagle Investment (Trades, Portfolio) with 0.69%, Steven Cohen (Trades, Portfolio) with 0.48%, Joel Greenblatt (Trades, Portfolio) with 10.19% and Pioneer Investments (Trades, Portfolio) with 0.1%.
Southwest Airlines Co. (LUV) is trading at the price of $43.81, but the Peter Lynch earnings line gives the company a fair price of $81.5, giving the stock a margin of safety of 47%. It is trading with a PE ratio of 13.44 that is ranked lower than 87% of its competitors in the Global Airlines industry, and is currently 14.63% below its 52-week high and 39.76% above its 52-week low.
The company reports a cash to debt of 0.91 that is above the industry median of 0.46, with ROE of 31.01% and ROA of 10.44% that are outperforming 75% of its competitors. It operates Southwest Airlines and AirTran Airways, passenger airlines that provide scheduled air transportation in the U.S. and near-international markets.
The company is held by seven gurus:Â PRIMECAP Management (Trades, Portfolio) is the largest shareholder among the gurus with a stake of 11.61% of outstanding shares, followed by David Tepper (Trades, Portfolio) with 0.67%, Barrow, Hanley, Mewhinney & Strauss with 0.51%, T Rowe Price Equity Income Fund (Trades, Portfolio) with 0.2%, Joel Greenblatt (Trades, Portfolio) with 0.2% and Pioneer Investments (Trades, Portfolio) with 0.06%.
